AMED is supporting R&D projects on
the novel coronavirus disease (COVID-19).
-
-
Our goal is to fast-track medical R&D
that directly benefits people,
not only by extending lifespans,
but also by improving quality of life. -
Your front-row seat to the best
Click here for details
Japanese medical science ideas
Become an AMED grant reviewer today. -
Our goal is to fast-track medical R&D
that directly benefits people,
not only by extending lifespans,
but also by improving quality of life.
What's New
-
11/12/21Unveiling the Landscape of Genomic Alterations in Adult T-Cell Leukemia/Lymphoma - A Demonstration of the Potent...
-
10/13/21AMED International Joint Symposium 2021: Promotion of Infectious Disease Research Cooperation between Africa and...
-
10/11/21Molecular landscape of multi-step virus carcinogenesis revealed by multi-modal single-cell analysis
News Release & Research Results
-
05/19/22New SATREPS Projects for FY 2022 under AMED International Collaborative Research Program
-
04/20/22Proposing a new concept that integrates species evolution and genetic evolution
-
03/28/22Comparison of clonal architecture between primary and immunodeficient mouse engrafted acute myeloid leukemia cel...
content
-
Overview
Introduction of AMED
-
Achievements
Introducing the results related to the programs that AMED's supports R&D
-
Intellectual Property
Protection and exploitation of intellectual property
-
Research Integrity
AMED promotes the measures in its Department of Research Integrity and Legal Affairs to ensure the fair and appropriate conducting of research
-
Collaboration / cooperation with external institutions
Collaboration / Cooperation with External Organizations
-
Brochure
Overview of the AMED, and selected programs summary etc.
-
Patient and Public Involvement (PPI)
Information on Patient and Public Involvement(PPI) in AMED
